Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysis
-
- Chenjing Zhu
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China
-
- Xuelei Ma
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China
-
- Yuanyuan Hu
- West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, PR China
-
- Linghong Guo
- West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, PR China
-
- Bo Chen
- Department of Oncology, The First People's Hospital of Chengdu City, Chengdu 610041, PR China
-
- Kai Shen
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041, PR China
-
- Yue Xiao
- West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610041, PR China
書誌事項
- 公開日
- 2016-06-14
- DOI
-
- 10.18632/oncotarget.10019
- 公開者
- Impact Journals, LLC
収録刊行物
-
- Oncotarget
-
Oncotarget 7 (28), 44545-44557, 2016-06-14
Impact Journals, LLC